Abstract:The activation of pro-inflammatory gene programs by nuclear factor-kappa B (NF-kappa B) is primarily regulated through cytoplasmic sequestration of NF-kappa B by the inhibitor of kappa B (I kappa B) family of proteins(1). I kappa B beta, a major isoform of I kappa B, can sequester NF-kappa B in the cytoplasm(2), although its biological role remains unclear. Although cells lacking IkBb have been reported(3,4), in vivo studies have been limited and suggested redundancy between I kappa B alpha and I kappa B beta(5). Like I kappa B alpha, I kappa B beta is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus(6-11). The crystal structure of I kappa B beta bound to p65 suggested this complex might bind DNA(12). In vitro, hypophosphorylated I kappa B beta can bind DNA with p65 and c-Rel, and the DNA-bound NF-kappa B:I kappa B beta complexes are resistant to I kappa B alpha, suggesting hypophosphorylated, nuclear I kappa B beta may prolong the expression of certain genes(9-11). Here we report that in vivo I kappa B beta serves both to inhibit and facilitate the inflammatory response. I kappa B beta degradation releases NF-kappa B dimers which upregulate proinflammatory target genes such as tumour necrosis factor-alpha (TNF-alpha). Surprisingly, absence of I kappa B beta results in a dramatic reduction of TNF-alpha in response to LPS even though activation of NF-kappa B is normal. The inhibition of TNF-alpha messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-I kappa B beta bound to p65:c-Rel heterodimers at a specific kappa B site on the TNF-alpha promoter. Therefore I kappa B beta acts through p65:c-Rel dimers to maintain prolonged expression of TNF-alpha. As a result, I kappa B beta(-/-) mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking I kappa B beta might be a promising new strategy for selectively inhibiting the chronic phase of TNF-alpha production during the inflammatory response.

Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

IκB Kinase Ε is an NFATc1 Kinase That Inhibits T Cell Immune Response.

KATP channel block inhibits the Toll-like receptor 2-mediated stimulation of NF-κB by suppressing the activation of Akt, mTOR, JNK and p38-MAPK

Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation Through Selective Activation of IκB Kinase Β

A Molecular Dissection of Lymphocyte Unresponsiveness Induced by Sustained Calcium Signalling.

LATS2 Inhibits the Activity of NF-κ B Signaling by Disrupting the Interaction Between TAK1 and IKKβ

Protein Phosphatase 2A Acts As a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced IκB Kinase Β/nuclear Factor-κB Activation

Pkd2 Interacts with Lck and Regulates Nfat Activity in T Cells

Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1

The Akt1 Isoform is Required for Optimal IFN-β Transcription Through Direct Phosphorylation of Β-Catenin

Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression

IκB Kinase is an Essential Component of the Tpl2 Signaling Pathway

Protein Kinase C-u Participates in NF-kB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IkB Kinase b

IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells

Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells

PP2A negatively regulates NK cell T-bet expression and anti-tumor effector function

Hyperactivation of nuclear factor of activated T cells 1 (NFAT1) in T cells attenuates severity of murine autoimmune encephalomyelitis

IKIP Negatively Regulates NF-κB Activation and Inflammation Through Inhibition of IKKα/β Phosphorylation

Nfatc1 Phosphorylation By Dyrk1a Increases Its Protein Stability